UnitedHealthcare softens colonscopy coverage policy after outcry; new data on Novartis breast cancer drug

Taking stock of the drug industry, from the lab to the medicine chest

June 2, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe After outcry, UnitedHealthcare softens prior authorization policy for colonoscopies Instead of requiring prior authorization to have GI procedures covered, the insurer is starting an "advanced notification" policy. By Angus Chen STAT+ | Novartis drug reduces breast cancer recurrence, but experts may debate results The findings will likely lead to regulatory approvals and broader use of the medicine, which may represent a financial windfall for Novartis. By Matthew Herper STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman Cliff Owen/AP Biden plans to pick Mandy Cohen to lead CDC Mandy Cohen spent five years leading North Carolina's health and human services department and had two stints at CMS. By Sarah Owermohle and Helen Branswell and Rachel Cohrs

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser